Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Imperative Care $100M GrowthTalkiatry $210M Series DRanked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Imperative Care $100M GrowthTalkiatry $210M Series DNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Understood Care $8.4M Pre-Seed+SeedOasys Health $4.6M Seed+Pre-SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Biocaptiva £15.8M Series ANami Surgical £1.9M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Biocaptiva £15.8M Series ANami Surgical £1.9M UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Greater Good Health $20.5M Series BCodoxo $35M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Antiverse $9.3M Series AFluoSphera €1.2M UndisclosedNew companies 1 · Follow-on 1
Stages: Series A 2
Poplar Therapeutics $45M Series A+Poplar Therapeutics $50M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Honest Health $140M Series BVieCure $43M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
The Biological Computing $25M SeedSomethings $19.2M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Alaffia Health $55M Series BOasys Health $4.6M Seed+Pre-SeedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Orbem €55.5M Series BViCentra $13M Series DNew companies 2 · Follow-on 0
Stages: Series A 2
Vibrant Therapeutics $61M Series ASpiro Medical $67M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
VieCure $43M UndisclosedVizgen $48M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.